01 1Astellas Pharma Canada Inc.
02 2CT Corporation System Canada Ltd.
03 1Blank
01 11292184
02 21336890
03 11339008
01 2Amphotericin B
02 1Liposomal Amphotericin B
03 1Blank
01 1Lyophilized powder for reconsititution
02 2Powder for Reconstitution
03 1Blank
01 12008-11-19
02 22012-09-05
03 12014-03-25
Patent Expiration Date : 2014-03-25
Date Granted : 1997-03-25
Brand Name : AMBISOME
Patent Number : 1339008
Filing Date : 1988-11-10
Strength per Unit : 50 mg amphotericin B per vial
Dosage Form : Lyophilized powder for reconsititution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2014-03-25
Date Granted : 1997-03-25
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Brand Name : AMPHOTEC
Patent Number : 1336890
Filing Date : 1988-02-29
Strength per Unit : 50mg VIAL
Dosage Form : Powder for Reconstitution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Brand Name : AMPHOTEC
Patent Number : 1336890
Filing Date : 1988-02-29
Strength per Unit : 100mg VIAL
Dosage Form : Powder for Reconstitution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-09-05
Date Granted : 1995-09-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2008-11-19
Date Granted :
Brand Name :
Patent Number : 1292184
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-11-19
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
